The Magazine for Sleep Professionals
Saturday, July 4, 2026
Incannex Healthcare Inc., a pharmaceutical company developing unique medicinal cannabinoid pharmacotherapies and psychedelic medicine therapies, is pleased to announce that patient dosing has commenced in the Company’s Phase 2/3 clinical trial to assess the safety and efficacy of IHL-42X in patients with obstructive sleep apnea (OSA). IHL-42X is the Company’s […]
IntelliPAP™ is a new optional tool for physicians to use in noninvasive ventilation for patients with respiratory insufficiency and obstructive sleep apnea (OSA). This innovative device automatically adjusts the positive end-expiratory pressure (PEEP) levels in response to sleep-disordered breathing (SDB) events. To enhance safety, clinicians can set minimum and maximum […]
ZOLL® has announced today that a new analysis of data from the remedē® System Pivotal Trial suggests favorable outcomes for heart failure (HF) patients with central sleep apnea (CSA). The analysis was performed post-hoc using a hierarchical endpoint comprised of mortality, HF hospitalization, and health status. The new analysis was […]
Fisher & Paykel Healthcare Corporation Limited has announced the launch of the F&P Solo™ Nasal mask in the USA for the treatment of obstructive sleep apnea (OSA). The world’s first AutoFit™ mask, F&P Solo, simplifies setup like no other, enabling users to stretch the mask onto the face and adjust […]
Sleep Specialists, LLC, developers of the FDA-cleared Zzoma® positional therapy device, and ISD Health Solutions, the leading provider of sleep disorder treatment in the Caribbean, today announced a partnership to bring the benefits of Zzoma to patients suffering from mild to moderate positional obstructive sleep apnea (OSA). This collaboration comes […]
It’s well understood and accepted that sleep position, in particular the supine position in which a person sleeps on their back with their face and abdomen facing upwards, is associated with an increase in sleep-disordered breathing.1 While over half of all cases of obstructive sleep apnea (OSA) are classified as […]
ResMed announced the U.S. launch of the AirFit F40, an ultra-compact, full-face mask offering the comfort of smaller masks without sacrificing performance in order to help improve sleep apnea therapy compliance.2 Finding the right mask with the right fit and comfort can be daunting, especially for individuals requiring high-pressure CPAP […]
As the prevalence of atrial fibrillation (AF) continues to rise, particularly among the aging population, its connection with obstructive sleep apnea (OSA) has become increasingly evident.1 Patients with AF seeking treatment for OSA often present with a complex medical history that includes a number of comorbidities, such as hypertension, acid […]
Sleep Specialists, LLC, the manufacturer of Zzoma®, the FDA-cleared positional therapy device for mild to moderate obstructive sleep apnea (OSA), announced a significant milestone today. More than 1,000 sleep specialists across the United States are now prescribing Zzoma to their patients, and over 800 sleep clinics are actively offering it […]
ResMed launched its AirCurve 11 series devices, the company’s newest bilevel devices that use two levels of support, inspiratory positive airway pressure (IPAP) and expiratory positive airway pressure (EPAP), combined with digital technology to make it easier for healthcare providers to treat sleep apnea and to help patients start and […]
